• 
    

    
    

      99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

      表沒(méi)食子兒茶素沒(méi)食子酸酯對(duì)IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞極化的影響①

      2017-12-20 03:22:22王衛(wèi)芳張曉靜崔夢(mèng)珂李衛(wèi)國(guó)王坤英
      中國(guó)免疫學(xué)雜志 2017年12期
      關(guān)鍵詞:骨髓細(xì)胞兒茶素極化

      王衛(wèi)芳 王 慧 張曉靜 崔夢(mèng)珂 李衛(wèi)國(guó) 王坤英

      (河南師范大學(xué)生命科學(xué)學(xué)院,新鄉(xiāng) 453007)

      表沒(méi)食子兒茶素沒(méi)食子酸酯對(duì)IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞極化的影響①

      王衛(wèi)芳 王 慧 張曉靜 崔夢(mèng)珂 李衛(wèi)國(guó) 王坤英

      (河南師范大學(xué)生命科學(xué)學(xué)院,新鄉(xiāng) 453007)

      目的探討表沒(méi)食子兒茶素沒(méi)食子酸酯(EGCG)對(duì)IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞促炎細(xì)胞因子表達(dá)的影響。方法取6~8周齡C57BL/6小鼠骨髓細(xì)胞,經(jīng)100 ng/ml巨噬細(xì)胞集落刺激因子(M-CSF)體外誘導(dǎo)分化為骨髓巨噬細(xì)胞(BMDM),加入50 ng/ml干擾素γ(IFN-γ)和1 μg/ml細(xì)菌脂多糖(LPS)刺激,并同時(shí)暴露于12.5~50 μmol/L EGCG處理48 h,利用實(shí)時(shí)熒光定量PCR(qRT-PCR)和酶聯(lián)免疫吸附試驗(yàn)(ELISA)檢測(cè)巨噬細(xì)胞促炎細(xì)胞因子IL-1β、TNF-α和iNOS的mRNA表達(dá)水平和蛋白含量。結(jié)果IFN-γ和LPS處理可刺激巨噬細(xì)胞IL-1β、TNF-α和iNOS表達(dá)顯著上調(diào),而EGCG則能抑制IFN-γ和LPS刺激的IL-1β、TNF-α和iNOS表達(dá),且存在劑量依賴(lài)性。結(jié)論EGCG能夠減弱IFN-γ和LPS刺激的髓源性巨噬細(xì)胞的促炎作用。

      髓源性巨噬細(xì)胞;表沒(méi)食子兒茶素沒(méi)食子酸酯;巨噬細(xì)胞極化

      巨噬細(xì)胞是一類(lèi)具有高度異質(zhì)性和可塑性的細(xì)胞群體,浸潤(rùn)于機(jī)體的大多數(shù)組織中,發(fā)揮著不同的作用[1]。起源于骨髓的單核細(xì)胞,經(jīng)血液循環(huán)進(jìn)入組織分化為巨噬細(xì)胞,在所處微環(huán)境因子的刺激下進(jìn)一步分化[2]。巨噬細(xì)胞極化分為經(jīng)典活化型巨噬細(xì)胞(M1)和替代活化型巨噬細(xì)胞(M2)。M1巨噬細(xì)胞由γ干擾素(Interferon-γ,IFN-γ)、細(xì)菌脂多糖(Lipopolysaccharide,LPS)誘導(dǎo)產(chǎn)生,可分泌多種促炎細(xì)胞因子和炎性介質(zhì),如腫瘤壞死因子(Tumor necrosis factor α,TNF-α)、白介素-1β(Interleukin-1β,IL-1β)、誘導(dǎo)型一氧化氮合酶(inducible nitric oxide synthesis,iNOS)等,通過(guò)清除病原體、壞死組織和激活其他免疫細(xì)胞以利于機(jī)體抵御感染。M2巨噬細(xì)胞由IL-4、IL-13誘導(dǎo)產(chǎn)生,與炎癥消退、腫瘤生長(zhǎng)維持、抗腸道寄生蟲(chóng)感染有關(guān),并參與組織修復(fù)等[3]。M1/M2型巨噬細(xì)胞的分化與許多疾病的發(fā)生發(fā)展都密切相關(guān),如Ⅱ型糖尿病、胰島素抵抗、癌癥、心血管疾病和神經(jīng)退行性疾病等[4]。

      表沒(méi)食子兒茶素沒(méi)食子酸酯(Epigallocatechin-3-gallate,EGCG)是綠茶多酚的主要活性成分,具有抗氧化、抗炎、抗癌等多種生物學(xué)效應(yīng)[5-7]。Jang等[8]研究發(fā)現(xiàn)經(jīng)EGCG處理的小鼠乳腺癌細(xì)胞系4T1能下調(diào)M2巨噬細(xì)胞的TGF-β分泌,表明EGCG能影響腫瘤相關(guān)巨噬細(xì)胞(Tumor-associated macrophages,TAM)的極化。本實(shí)驗(yàn)室的研究表明EGCG抑制LPS誘導(dǎo)的小鼠RAW264.7細(xì)胞促炎因子TNF-α和IL-1β基因表達(dá)和生成,并能影響IL-4刺激的小鼠腹腔巨噬細(xì)胞精氨酸酶-1(Arginase,Arg-1)和誘導(dǎo)性一氧化氮合酶(iNOS)表達(dá)[9,10]。但是,EGCG能否影響小鼠髓源性巨噬細(xì)胞(Myeloid macrophages)極化,未見(jiàn)研究報(bào)道。本研究將通過(guò)實(shí)時(shí)熒光定量PCR(quantitative real-time PCR,qRT-PCR)和酶聯(lián)免疫吸附試驗(yàn)(Enzyme linked immunosorbent assay,ELISA)檢測(cè)巨噬細(xì)胞促炎因子TNF-α、IL-1β和iNOS的mRNA水平和蛋白生成,探討EGCG對(duì)髓源性巨噬細(xì)胞極化的影響作用。

      1 材料與方法

      1.1材料

      1.1.1實(shí)驗(yàn)動(dòng)物 實(shí)驗(yàn)選用6~8周齡、體重(20±3)g的清潔級(jí)C57BL/6小鼠,雌雄比例1∶1,購(gòu)自濟(jì)南朋悅實(shí)驗(yàn)動(dòng)物繁育有限公司。正常膳食喂養(yǎng),光照∶黑暗為12 h∶12 h。

      1.1.2主要試劑 實(shí)驗(yàn)使用的RPMI1640培養(yǎng)液為HyClone公司產(chǎn)品,血清為四季青公司產(chǎn)品,紅細(xì)胞裂解液為Solarbio公司產(chǎn)品,重組小鼠M-CSF為R&D公司產(chǎn)品,IFN-γ為PeproTech公司產(chǎn)品,RNAiso Plus和cDNA第一合成試劑盒為T(mén)aKaRa公司產(chǎn)品,qRT-PCR試劑盒為Vazyme Biotech公司產(chǎn)品,qRT-PCR引物由上海捷瑞生物工程有限公司合成,IL-1β、TNF-α和iNOS的ELISA試劑盒為南京森貝伽生物科技有限公司產(chǎn)品。

      1.2實(shí)驗(yàn)方法

      1.2.1小鼠骨髓細(xì)胞分離培養(yǎng) 將小鼠頸椎脫臼處死后,無(wú)菌條件下分離股骨和脛骨,用完全培養(yǎng)基將骨髓內(nèi)容物吹入無(wú)菌平皿內(nèi)分散均勻。離心、棄上清后,加入紅細(xì)胞裂解液裂解紅細(xì)胞,30 s后用完全培養(yǎng)基終止裂解。經(jīng)離心、重懸后,置于37℃、5%CO2培養(yǎng)箱中孵育2 h,收集未貼壁的骨髓細(xì)胞。

      1.2.2髓源性巨噬細(xì)胞的誘導(dǎo)和分組處理 將收集的骨髓細(xì)胞鋪于6孔細(xì)胞培養(yǎng)板中,1×106個(gè)細(xì)胞/孔。按實(shí)驗(yàn)設(shè)計(jì)將骨髓細(xì)胞分為5組,即對(duì)照組、LPS/IFN-γ處理組以及3個(gè)LPS/IFN-γ與EGCG共處理組。依Ying等[11]的方法,各組骨髓細(xì)胞經(jīng)100 ng/ml M-CSF誘導(dǎo)7 d分化為巨噬細(xì)胞,第3天時(shí)更換含M-CSF的新鮮培養(yǎng)液一次。在M-CSF誘導(dǎo)第5天時(shí),LPS/IFN-γ處理組加入1 μg/ml LPS和50 ng/ml IFN-γ培養(yǎng)48 h,而3個(gè)LPS/IFN-γ與EGCG共處理組則在加入1 μg/ml LPS和50 ng/ml IFN-γ的同時(shí)分別加入12.5 μmol/L、25 μmol/L和50 μmol/L的EGCG培養(yǎng)48 h。

      1.2.3巨噬細(xì)胞促炎細(xì)胞因子mRNA水平的qRT-PCR分析 收集誘導(dǎo)處理7 d后的細(xì)胞,提取RNA,并按反轉(zhuǎn)錄試劑盒操作說(shuō)明,去除基因組DNA,進(jìn)行cDNA第一鏈的合成,并置于4℃保存。按照標(biāo)準(zhǔn)qRT-PCR引物設(shè)計(jì)原則,運(yùn)用primer 5.0軟件設(shè)計(jì)IL-1β、TNF-α和iNOS的引物序列(表1)。

      qRT-PCR反應(yīng)按兩步法標(biāo)準(zhǔn)程序設(shè)置:95℃預(yù)變性5 min,95℃變性10 s、退火60 s、延伸30 s,共40個(gè)循環(huán)。然后依照qRT-PCR試劑盒操作說(shuō)明在羅氏Light Cycler?96熒光定量PCR儀上完成實(shí)驗(yàn)。實(shí)驗(yàn)所得數(shù)據(jù)則按照2-ΔΔCt法進(jìn)行計(jì)算,并進(jìn)行統(tǒng)計(jì)學(xué)分析。

      1.2.4巨噬細(xì)胞促炎細(xì)胞因子含量的ELISA檢測(cè) 收集誘導(dǎo)處理7 d后的細(xì)胞培養(yǎng)液放入-80℃冰箱,以備ELISA法檢測(cè)細(xì)胞IL-1β和TNF-α的分泌量。然后用預(yù)熱PBS清洗后,按照6孔板每孔加入200 μl細(xì)胞裂解液,混勻后,10 000~14 000 g離心3~5 min,取上清用ELISA試劑盒檢測(cè)iNOS含量。

      2 結(jié)果

      2.1EGCG抑制IFN-γ/LPS刺激的髓源性巨噬細(xì)胞IL-1β基因表達(dá)和蛋白生成 小鼠骨髓細(xì)胞經(jīng)100 ng/ml M-CSF誘導(dǎo)分化為髓源性巨噬細(xì)胞。運(yùn)用qRT-PCR分析表明,與對(duì)照組巨噬細(xì)胞相比,經(jīng)50 ng/ml IFN-γ和1 μg/ml LPS聯(lián)合處理的巨噬細(xì)胞IL-1β mRNA表達(dá)水平極顯著地上調(diào),存在極顯著性差異;與50 ng/ml IFN-γ和1 μg/ml LPS聯(lián)合處理組細(xì)胞相比,12.5~50 μmol/L EGCG處理可抑制IFN-γ/LPS誘導(dǎo)的巨噬細(xì)胞IL-1β基因表達(dá)上調(diào),12.5 μmol/L EGCG處理組細(xì)胞的IL-1β mRNA水平顯著下調(diào)(P<0.05),而25 μmol/L和50 μmol/L EGCG處理組細(xì)胞的IL-1β mRNA水平呈極顯著下調(diào)(P<0.01)(圖1A)。運(yùn)用ELISA技術(shù)檢測(cè)顯示,與對(duì)照組巨噬細(xì)胞相比,50 ng/ml IFN-γ和1 μg/ml LPS聯(lián)合刺激可使髓源性巨噬細(xì)胞的IL-1β蛋白生成極顯著性增加(P<0.01),而12.5~50 μmol/LEGCG處理可極顯著性地抑制IFN-γ和LPS聯(lián)合刺激的IL-1β生成(P<0.01)(圖1B)。這些結(jié)果提示EGCG能夠抑制IFN-γ和LPS聯(lián)合刺激的小鼠髓源性M1巨噬細(xì)胞的IL-1β表達(dá)和生成,且存在劑量依賴(lài)效應(yīng)。

      表1IL-1β、TNF-α和iNOS基因的引物序列

      Tab.1PrimersequencesofIL-1β,TNF-αandiNOSgene

      GenePrimers5'→3'IL-1βForward:CAGGCAGTATCACTCATT-GTGGCIL-1βReverse:CAGCAGGTTATCATCAT-CATCCCTNF-αForward:GAGTGACAAGCCTGTAGCCTNF-αReverse:CTCCTGGTATGAGATAG-CAAAiNOSForward:CACCAAGCTGAACTT-GAGCGiNOSReverse:GTGGCTTTGGGCTCCTCβ-actinForward:CGTCAGGCAGCTCAT-AGCTCTTCTβ-actinReverse:TGGCTACAGCTTCACCAC-CACAG

      圖1 EGCG抑制IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞IL-1β基因表達(dá)和生成Fig.1 EGCG inhibits IL-1β gene expression and IL-1β production stimulated by IFN-γ/LPS in murine myeloid macrophagesNote: The myeloid cells were isolated from bone marrow,cultured with RPMI1640 medium contained 10% FBS.After induced with M-CSF(100 ng/ml)for 7 days,the myeloid cells differentiated into the myeloid macrophages.At 5th day,the myeloid macrophages were induced to M1 macrophage stimulated with 50 ng/ml IFN-γ and 1 μg/ml LPS,and at the same time,these cells were treated with 12.5 μmol/L,25 μmol/L,and 50 μmol/L EGCG for 48 h,respectively.After macrophages were harvested,the IL-1β mRNA level was analyzed with qRT-PCR(A),and the IL-1β level was detected with ELISA(B).**.P<0.01,compared with control;#.P<0.05 and ##.P<0.01,compared with IFN-γ+LPS group.

      2.2EGCG抑制IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞TNF-α基因表達(dá)及生成 體外分離培養(yǎng)的小鼠骨髓細(xì)胞經(jīng)M-CSF誘導(dǎo)分化為髓源性巨噬細(xì)胞,進(jìn)一步在IFN-γ和LPS刺激下,分化為M1型巨噬細(xì)胞,并分泌細(xì)胞因子TNF-α。運(yùn)用qRT-PCR分析表明,M-CSF單獨(dú)誘導(dǎo)的對(duì)照組髓源性巨噬細(xì)胞TNF-α mRNA幾乎不表達(dá),經(jīng)IFN-γ和LPS聯(lián)合刺激后,髓源性巨噬細(xì)胞的TNF-α mRNA水平極顯著性的增加(P<0.01);與IFN-γ和LPS聯(lián)合刺激組的髓源性巨噬細(xì)胞相比,12.5~50 μmol/L EGCG處理后,巨噬細(xì)胞的TNF-α mRNA水平出現(xiàn)下降,且在50 μmol/L EGCG處理時(shí)下降最為明顯,呈現(xiàn)劑量依賴(lài)效應(yīng)(圖2A)。運(yùn)用ELISA檢測(cè)顯示,與對(duì)照組巨噬細(xì)胞相比,IFN-γ和LPS聯(lián)合刺激組的巨噬細(xì)胞TNF-α生成量極顯著性增加(P<0.01);而經(jīng)12.5~50 μmol/L EGCG 處理后,巨噬細(xì)胞TNF-α生成量出現(xiàn)極顯著性下降(P<0.01)(圖2B)。這些結(jié)果提示EGCG能夠抑制IFN-γ和LPS聯(lián)合刺激的小鼠髓源性M1巨噬細(xì)胞的TNF-α表達(dá)和生成,且存在劑量依賴(lài)效應(yīng)。

      圖2 EGCG抑制IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞TNF-α基因表達(dá)和生成Fig.2 EGCG represses TNF-α gene expression and TNF-α production stimulated by IFN-γ/LPS in mlurine myeloid macrophagesNote: The experimental method is same as Fig 1.After macrophages were harvested,the TNF-α mRNA level was analyzed with qRT-PCR(A),and the TNF-α level was detected with ELISA(B).**.P<0.01,compared with control;##.P<0.01,compared with IFN-γ+LPS group.

      圖3 EGCG抑制IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞iNOS基因表達(dá)和生成Fig.3 EGCG decreases iNOS gene expression and iNOS production stimulated by IFN-γ/LPS in murine myeloid macrophagesNote: The experimental method is same as Fig 1.After macrophages were harvested,the iNOS mRNA level was analyzed with qRT-PCR(A),and the iNOS level was detected with ELISA(B).**.P<0.01,compared with control;##.P<0.01,compared with IFN-γ+LPS group.

      2.3EGCG抑制IFN-γ/LPS刺激的小鼠髓源性巨噬細(xì)胞iNOS基因表達(dá)及生成 巨噬細(xì)胞在IFN-γ或LPS的刺激下極化為M1型巨噬細(xì)胞,高表達(dá)iNOS,并產(chǎn)生NO,因而iNOS是M1型巨噬細(xì)胞的重要標(biāo)志物。運(yùn)用qRT-PCR分析表明,經(jīng)M-CSF單獨(dú)誘導(dǎo)的對(duì)照組髓源性巨噬細(xì)胞iNOS mRNA幾乎不表達(dá),經(jīng)IFN-γ和LPS聯(lián)合刺激后,髓源性巨噬細(xì)胞的iNOS mRNA水平極顯著性增加(P<0.01);與IFN-γ和LPS聯(lián)合刺激組的髓源性巨噬細(xì)胞相比,12.5~50 μmol/L EGCG處理后,巨噬細(xì)胞的iNOS mRNA水平出現(xiàn)下降,并隨著EGCG濃度增加,下降幅度越大,呈現(xiàn)出明顯的劑量依賴(lài)效應(yīng)(圖3A)。運(yùn)用ELISA檢測(cè)顯示,與對(duì)照組巨噬細(xì)胞相比,IFN-γ和LPS聯(lián)合刺激組的巨噬細(xì)胞iNOS生成量極顯著性增加(P<0.01);而經(jīng)12.5~50 μmol/L EGCG 處理后,巨噬細(xì)胞iNOS生成量出現(xiàn)極顯著性下降(P<0.01)(圖3B)。這些結(jié)果提示EGCG能夠抑制IFN-γ和LPS聯(lián)合刺激的小鼠髓源性M1巨噬細(xì)胞的iNOS表達(dá)和生成,且存在劑量依賴(lài)效應(yīng)。

      3 討論

      眾所周知,巨噬細(xì)胞極化是機(jī)體免疫系統(tǒng)維持免疫穩(wěn)態(tài)的一個(gè)動(dòng)態(tài)過(guò)程,某些特定疾病的發(fā)生條件與巨噬細(xì)胞極化密切相關(guān),了解這些機(jī)制將有利于疾病的治療[12],而骨髓來(lái)源的巨噬細(xì)胞(Bone marrow-derived macrophages,BMDM)是研究巨噬細(xì)胞極化的適宜細(xì)胞模型[11]。巨噬細(xì)胞的發(fā)育與分化依賴(lài)于巨噬細(xì)胞集落刺激因子(Macrophages colony-stimulating factor,M-CSF)的誘導(dǎo),骨髓細(xì)胞在M-CSF誘導(dǎo)下激活ERK1/2通路,促使骨髓前體細(xì)胞向巨噬細(xì)胞分化[13];巨噬細(xì)胞在IFN-γ和LPS刺激下極化成M1型巨噬細(xì)胞。LPS能與巨噬細(xì)胞表面的Toll樣受體4(Toll-like receptor 4,TLR4)結(jié)合,經(jīng)Akt1/2誘導(dǎo)巨噬細(xì)胞極化[14],進(jìn)而增強(qiáng)促炎細(xì)胞因子的基因表達(dá)和分泌[15,16];而IFN-γ可進(jìn)一步增強(qiáng)M1型巨噬細(xì)胞的活化。

      在本實(shí)驗(yàn)中,M-CSF誘導(dǎo)小鼠骨髓細(xì)胞形成BMDM,后者在IFN-γ和LPS刺激下極化為M1型巨噬細(xì)胞,其分泌的IL-1β、TNF-α、iNOS在mRNA表達(dá)水平是增加的,并且具有極顯著性差異。這與Ying等[11]的實(shí)驗(yàn)結(jié)果一致的,他們將小鼠骨髓細(xì)胞經(jīng)M-CSF誘導(dǎo)形成髓源性巨噬細(xì)胞,IFN-γ和LPS刺激1周后,檢測(cè)顯示巨噬細(xì)胞的IL-1β、TNF-α表達(dá)水平顯著上升;流式細(xì)胞術(shù)檢測(cè)也顯示巨噬細(xì)胞的表面標(biāo)記物CD11b、F4/80、CD206表達(dá)增強(qiáng);同時(shí)還發(fā)現(xiàn)細(xì)胞的p65可在IFN-γ和LPS刺激后活化,表明巨噬細(xì)胞極化與p65活化相關(guān)。本實(shí)驗(yàn)中,EGCG和LPS/IFN-γ共處理后,M1型巨噬細(xì)胞促炎細(xì)胞因子IL-1β、TNF-α和iNOS表達(dá)下降,表明EGCG能降低LPS/IFN-γ刺激的巨噬細(xì)胞促炎細(xì)胞因子表達(dá)。

      EGCG通過(guò)何種機(jī)制調(diào)控LPS/IFN-γ刺激的巨噬細(xì)胞促炎細(xì)胞因子表達(dá)和生成?有研究表明,EGCG可通過(guò)細(xì)胞膜表面的67 kD層黏連蛋白受體(67-kD laminin receptor,67 LR)機(jī)制介導(dǎo)促炎細(xì)胞因子的分泌[17],EGCG不但通過(guò)67 LR抑制IKKβ活性進(jìn)而阻斷NF-κB通路的活化[18],而且還能通過(guò)67 LR下調(diào)LPS刺激的巨噬細(xì)胞TLR4信號(hào)轉(zhuǎn)導(dǎo)作用,抑制絲裂原活化蛋白激酶(Mitogen activated protein kinase,MAPK)的激活,進(jìn)而減少促炎細(xì)胞因子的生成[19,20]。EGCG也可通過(guò)AMP激活的蛋白激酶(Adenosine 5′-monophosphate-activated protein kinase,AMPK)抑制LPS刺激的促炎細(xì)胞因子TNF-α、IL-6和iNOS的生成[21]。有學(xué)者發(fā)現(xiàn)EGCG抑制LPS誘導(dǎo)的巨噬細(xì)胞產(chǎn)生NO時(shí),還能夠抑制Rab5與小凹蛋白-1(caveolin-1)的相互作用以及降低Rab5的活性,這些現(xiàn)象提示EGCG的這些作用是通過(guò)抑制LPS的內(nèi)吞作用進(jìn)而干擾Rab5與caveolin-1的相互作用和降低Rab5的活性實(shí)現(xiàn)的[22]。在THP-1巨噬細(xì)胞上的研究顯示,EGCG抑制LPS刺激的IL-1β和TNF-α表達(dá)的機(jī)制并不僅僅依賴(lài)于經(jīng)典的NF-κB、MAPK信號(hào)通路[23],提示EGCG抗炎機(jī)制可能是通過(guò)多種信號(hào)通路組成的調(diào)控網(wǎng)絡(luò)實(shí)現(xiàn)的,但這還需要更多的實(shí)驗(yàn)證據(jù)予以支持。

      本研究表明EGCG能夠下調(diào)IFN-γ和LPS刺激的髓源性巨噬細(xì)胞促炎細(xì)胞因子IL-1β、TNF-α和iNOS表達(dá),抑制巨噬細(xì)胞向M1型巨噬細(xì)胞極化,降低其炎性反應(yīng),這為EGCG在防治炎性疾病方面的潛在作用提供了一定的實(shí)驗(yàn)依據(jù)。

      [1] Ginhoux F,Jung S.Monocytes and macrophages:developmental pathways and tissue homeostasis[J].Nat Rev Immunol,2014,14(6):392-404.

      [2] Biswas SK,Chittezhath M,Shalova IN,etal.Macrophage polarization and plasticity in health and disease[J].Immunol Res,2012,53(1-3):11-24.

      [3] Galli SJ,Borregaard N,Wynn TA.Phenotypic and functional plasticity of cells of innate immunity:macrophages,mast cells and neutrophils[J].Nat Immunol,2011,12(11):1035-1044.

      [4] Liu Y,Cao X.The origin and function of tumor-associated macrophages[J].Cell Mol Immunol,2015,12(1):1-4.

      [5] Afzal M,Safer AM,Menon M.Green tea polyphenols and their potential role in health and disease[J].Inflammopharmacology,2015,23(4):151-161.

      [6] Niedzwiecki A,Roomi MW,Kalinovsky T,etal.Anticancer efficacy of polyphenols and their combinations[J].Nutrients,2016,8(9):E552.

      [7] Oz HS.Chronic inflammatory diseases and green tea polyphenols[J].Nutrients,2017,9(6):E561.

      [8] Jang JY,Lee JK,Jeon YK,etal.Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization[J].BMC Cancer,2013,13:421.

      [9] 張東芳,肖 鵬,韓晨露,等.表沒(méi)食子兒茶素-3-沒(méi)食子酸酯抑制脂多糖誘導(dǎo)的巨噬細(xì)胞促炎因子TNF-α和IL-1β基因表達(dá)[J].中國(guó)生物化學(xué)與分子生物學(xué)報(bào),2014,30(4):402-408.

      [10] 劉 敏,肖 鵬,李衛(wèi)國(guó),等.表沒(méi)食子兒茶素沒(méi)食子酸酯對(duì)白介素-4刺激的小鼠腹腔巨噬細(xì)胞精氨酸酶-1和誘導(dǎo)性一氧化氮合酶表達(dá)的影響[J].河南師范大學(xué)學(xué)報(bào)(自然科學(xué)版),2016,44(4):101-105.

      [11] Ying W,Cheruku PS,Bazer FW,etal.Investigation of macrophage polarization using bone marrow derived macrophages[J].J Vis Exp,2013,(76):50323.

      [12] Mcwhorter FY,Wang T,Nguyen P,etal.Modulation of macrophage phenotype by cell shape[J].Proc Nat Acad Sci U S A,2013,110(43):17253-17258.

      [13] Richardson ET,Shukla S,Nagy N,etal.ERK signaling is essential for macrophage development[J].PLoS One,2015,10(10):e0140064.

      [14] Arranz A,Doxaki C,Vergadi E,etal.Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization[J].Proc Natl Acad Sci U S A,2012,109(24):9517-9522.

      [15] Rossol M,Heine H,Meusch U,etal.LPS-induced cytokine production in human monocytes and macrophages[J].Crit Rev Immunol,2011,31(5):379-446.

      [16] Bode JG,Ehlting C,H?ussinger D.The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis[J].Cell Signal,2012,24(6):1185-1194.

      [17] Fujimura Y,Sumida M,Sugihara K,etal.Green tea polyphenol EGCG sensing motif on the 67-kD laminin receptor[J].PLoS One,2012,7(5):e37942.

      [18] Joo SY,Song YA,Park YL,etal.Epigallocatechin-3-gallate inhibits LPS-induced NF-κB and MAPK signaling pathways in bone marrow-derived macrophages[J].Gut Liver,2012,6(2):188-196.

      [19] Byun EB,Choi HG,Sung NY,etal.Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on lipopolysaccharide-stimulated dendritic cells[J].Biochem Biophys Res Commun,2012,426(4):480-485.

      [20] Byun EB,Mi-So Yang,Kim JH,etal.Epigallocatechin-3-gallate-mediated Tollip induction through the 67-kDa laminin receptor negatively regulating TLR4 signaling in endothelial cells[J].Immunobiology,2014,219(11):866-872.

      [21] Peairs A,Dai R,Gan L,etal.Epigallocatechin-3-gallate(EGCG)attenuates inflammation in MRL/lpr mouse mesangial cells[J].Cell Mol Immunol,2010,7(2):123-132.

      [22] Hagiwara M,Matsushita K.Epigallocatechin gallate suppresses LPS endocytosis and nitric oxide production by reducing Rab5-caveolin-1 interaction[J].Biomed Res,2014,35(2):145-151.

      [23] Wang T,Xiang Z,Wang Y,etal.(-)-Epigallocatechin gallate targets Notch to attenuate the inflammatory response in the immediate early stage in human macrophages[J].Front Immunol,2017,8:433.

      Influenceofepigallocatechin-3-gallateonmyeloidmacrophagespolarizationinducedwithIFN-γ/LPSinmice

      WANGWei-Fang,WANGHui,ZHANGXiao-Jing,CUIMeng-Ke,LIWei-Guo,WANGKun-Ying.

      CollegeofLifeScience,HenanNormalUniversity,Xinxiang453007,China

      Objective:To investigate the effect of epigallocatechin-3-gallate(EGCG)on the expression of pro-inflammatory cytokines in murine bone marrow-derived macrophages(BMDM)induced by IFN-γ/LPS.MethodsThe bone marrow cells were isolated from 6-8 weeks C57BL/6 mice,which cultured in RPMI1640 medium with 10% FBS and stimulated with 100 ng/ml M-CSFinvitro,and then exposed to 50 ng/ml IFN-γ and 1 μg/ml LPS with various concentrations of EGCG(12.5-50 μmol/L).The expression of pro-inflammatory factors,IL-1β,TNF-α and iNOS were detected,in murine myeloid macrophages stimulated by IFN-γ/LPS with qRT-PCR and ELISA.ResultsIFN-γ/LPS remarkably up-regulated the expression levels of inflammatory cytokines,IL-1β,TNF-α and iNOS,but EGCG effectively repressed these cytokines expression in IFN-γ/LPS-stimulated murine myeloid macrophages,in dose-dependent manner.ConclusionEGCG attenuates the pro-inflammatory phenotype of murine myeloid macrophages stimulated with IFN-γ/LPS.

      Myeloid macrophages;Epigallocatechin-3-gallate;Macrophage polarization

      10.3969/j.issn.1000-484X.2017.12.011

      R392.12

      A

      1000-484X(2017)12-1810-05

      ①本文受河南省重點(diǎn)科技攻關(guān)計(jì)劃(No.122102310282)項(xiàng)目資助。

      王衛(wèi)芳(1990年-), 女, 在讀碩士, 主要從事巨噬細(xì)胞極化方面的研究,E-mail:1475165901@qq.com。

      及指導(dǎo)教師:李衛(wèi)國(guó)(1963年-), 男, 博士, 教授, 碩士生導(dǎo)師, 主要從事細(xì)胞免疫學(xué)方面的研究,E-mail:liwg0618@ htu.cn。

      [收稿2017-04-20 修回2017-06-29]

      (編輯 張曉舟)

      猜你喜歡
      骨髓細(xì)胞兒茶素極化
      認(rèn)知能力、技術(shù)進(jìn)步與就業(yè)極化
      超高效液相色譜法測(cè)定茶葉中的兒茶素
      案例微課-翻轉(zhuǎn)課堂教學(xué)法在骨髓細(xì)胞形態(tài)臨床教學(xué)中的應(yīng)用
      雙頻帶隔板極化器
      基于PWM控制的新型極化電源設(shè)計(jì)與實(shí)現(xiàn)
      骨髓細(xì)胞涂片會(huì)診中存在的問(wèn)題及影響因素*
      急性白血病患者骨髓細(xì)胞LIMD1,VEGF-C,CTGF和Survivin的mRNA異常表達(dá)及相關(guān)性研究
      全甲基化沒(méi)食子兒茶素沒(méi)食子酸酯的制備
      兒茶素酶促制備茶黃素的研究進(jìn)展
      茶葉通訊(2014年2期)2014-02-27 07:55:38
      極化InSAR原理與應(yīng)用
      周至县| 苍山县| 红原县| 榆社县| 安图县| 呼伦贝尔市| 安塞县| 荣成市| 涞源县| 黑河市| 连江县| 蓬溪县| 布尔津县| 临西县| 鄂州市| 冕宁县| 广汉市| 裕民县| 天峻县| 民乐县| 西盟| 星子县| 襄城县| 文昌市| 称多县| 南华县| 江口县| 周口市| 济南市| 邵武市| 贺州市| 宜兰县| 梁平县| 大庆市| 深州市| 始兴县| 繁峙县| 江门市| 阳春市| 卓资县| 株洲市|